MarketPeel
Insider Trading Intelligence
Pricing
…
CJ

Cecilia Jones

AGIO
CHIEF FINANCIAL OFFICER · AGIOS PHARMACEUTICALS, INC. · CIK 0001840056
FILING MIX · LIFETIME47%/53%
BUYS
27
SELLS
31
TOTAL VALUE
$895.7K
COMPANIES
1
ACTIVE SINCE
Sep 2022
HOLDINGS NOW
3,000
AVG SELL PX
$32.35
TRADE KIND
SHOWING 58 / 58
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
12 backtested trades · 8 horizons · 16 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Cecilia Jones, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d12+66.67%-2.31%-0.04%-2.27%-0.65%—
14d12+66.67%-0.84%+0.73%-1.58%+0.09%—
30d12+50.00%+3.40%+1.11%+2.29%-3.67%—
60d12+58.33%+1.47%+3.26%-0.16%-5.95%—
90d12+41.67%+3.66%+4.49%-0.23%-4.56%—
180d12(3 pending)+44.44%+14.83%+9.70%+5.13%-4.62%—
1y12(5 pending)+28.57%+25.88%+22.50%+3.38%-8.21%—
2y12(8 pending)+25.00%+23.88%+45.23%-21.35%-18.40%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
AGIO · 3,000 shares · as of Jun 18, 2026
029,59859,19588,793118,3902023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 27 buys / 31 sellsCOVERAGE · 16 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
AGIO
AGIOS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
3,000——3,000Jun 18, 2026Jun 23, 2026 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
3,000——9,000Jun 18, 2026Jun 23, 2026 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
PURCHASE
Chief Financial Officer
8,500——58,139Apr 2, 2026Apr 6, 2026 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
8,500——8,500Apr 2, 2026Apr 6, 2026 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
3,141$34.71$109.0K54,998Apr 2, 2026Apr 6, 2026 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
594$28.96$17.2K38,800Mar 2, 2026Mar 3, 2026 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
2,000——0Mar 2, 2026Mar 3, 2026 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
PURCHASE
Chief Financial Officer
5,303——50,901Mar 2, 2026Mar 3, 2026 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
PURCHASE
Chief Financial Officer
2,000——39,394Mar 2, 2026Mar 3, 2026 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
5,303——10,607Mar 2, 2026Mar 3, 2026 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
1,573$28.96$45.6K49,328Mar 2, 2026Mar 3, 2026 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
1,681$28.96$48.7K42,785Mar 2, 2026Mar 3, 2026 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
5,666——5,667Mar 2, 2026Mar 3, 2026 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
1,187$28.96$34.4K45,598Mar 2, 2026Mar 3, 2026 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
4,000——8,000Mar 2, 2026Mar 3, 2026 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
PURCHASE
Chief Financial Officer
5,666——44,466Mar 2, 2026Mar 3, 2026 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
PURCHASE
Chief Financial Officer
4,000——46,785Mar 2, 2026Mar 3, 2026 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
52,000——52,000Mar 1, 2026Mar 3, 2026 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
14,000——14,000Mar 1, 2026Mar 3, 2026 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
2,932$27.09$79.4K37,394Dec 30, 2025Jan 2, 2026 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
6,000——0Dec 30, 2025Jan 2, 2026 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
PURCHASE
Chief Financial Officer
6,000——40,326Dec 30, 2025Jan 2, 2026 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
7,472——0Sep 26, 2025Sep 30, 2025 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
PURCHASE
Chief Financial Officer
7,472——37,521Sep 26, 2025Sep 30, 2025 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
3,651$36.77$134.2K33,870Sep 26, 2025Sep 30, 2025 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
1,780$33.54$59.7K30,049Jun 24, 2025Jun 26, 2025 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
6,000——6,000Jun 24, 2025Jun 26, 2025 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
PURCHASE
Chief Financial Officer
6,000——31,829Jun 24, 2025Jun 26, 2025 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
1,681$35.54$59.7K25,829Mar 3, 2025Mar 4, 2025 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
594$35.54$21.1K21,843Mar 3, 2025Mar 4, 2025 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
5,667——11,333Mar 1, 2025Mar 4, 2025 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
43,500——43,500Mar 1, 2025Mar 4, 2025 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
PURCHASE
Chief Financial Officer
5,667——27,510Mar 1, 2025Mar 4, 2025 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
12,000——12,000Mar 1, 2025Mar 4, 2025 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
2,000——2,000Mar 1, 2025Mar 4, 2025 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
PURCHASE
Chief Financial Officer
2,000——22,437Mar 1, 2025Mar 4, 2025 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
15,910——15,910Mar 1, 2025Mar 4, 2025 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
7,473——7,472Sep 26, 2024Sep 30, 2024 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
2,542$49.03$124.6K20,158Sep 26, 2024Sep 30, 2024 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
PURCHASE
Chief Financial Officer
7,473——22,700Sep 26, 2024Sep 30, 2024 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
672$32.57$21.9K14,840Mar 5, 2024Mar 5, 2024 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
17,000——17,000Mar 1, 2024Mar 5, 2024 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
60,000——60,000Mar 1, 2024Mar 5, 2024 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
PURCHASE
Chief Financial Officer
2,000——15,512Mar 1, 2024Mar 5, 2024 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
2,000——4,000Mar 1, 2024Mar 5, 2024 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
1,886$21.64$40.8K13,069Jan 24, 2024Jan 24, 2024 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
5,380——0Jan 20, 2024Jan 24, 2024 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
PURCHASE
Chief Financial Officer
5,380——14,955Jan 20, 2024Jan 24, 2024 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
2,179$24.79$54.0K9,575Sep 28, 2023Sep 28, 2023 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
PURCHASE
Chief Financial Officer
7,472——11,754Sep 26, 2023Sep 28, 2023 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
7,472——14,945Sep 26, 2023Sep 28, 2023 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
1,597$28.36$45.3K3,783Jun 30, 2023Jun 30, 2023 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
PURCHASE
Chief Financial Officer
5,380——5,380Jun 28, 2023Jun 30, 2023 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
5,380——5,380Jun 28, 2023Jun 30, 2023 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
22,000——22,000Mar 1, 2023Mar 3, 2023 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
6,000——6,000Mar 1, 2023Mar 3, 2023 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
118,390——118,390Sep 26, 2022Sep 28, 2022 ↗View →
AGIO
AGIOS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
22,417——22,417Sep 26, 2022Sep 28, 2022 ↗View →
Other insiders · AGIO
Loading peer insiders…
About this filer
CIK 0001840056
ROLE
Chief Financial Officer
PRIMARY
AGIO
COMPANIES
1
ACTIVE SINCE
Sep 2022
MARKETPEEL · /INSIDER/0001840056DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback